Albany Molecular Research, Inc.

Founded in 1991, Albany Molecular Research, Inc. (Nasdaq: AMRI) is a chemistry-based drug discovery, development and manufacturing company, focusing on small molecule prescription drugs. AMRI provides chemistry expertise at all stages of the drug discovery process (see chart below), from identifying leads for validated targets, to lead optimization, scale-up, in vitro metabolism, and cGMP synthesis and manufacturing for clinical trials and commercial products. To complement these capabilities, AMRI maintains an in-house analytical chemistry department with state-of-the-art analytical equipment.Company research has led to dozens of issued and pending patents, including important patents for the active ingredient in the non-sedating antihistamine, Allegra, developed and marketed by Sanofi-Aventis. A key strategy of the company is to develop, acquire and apply promising new technology in order to bring added value to drug discovery and development projects.

Contact Details: 21 Corporate CirclePO Box 15098 Albany New York 12212-5098 United States of America Tel: 518-464-0279 Fax: 518-464-0289 Email: info@albmolecular.com WWW: www.albmolecular.com/

Loading...

Press Releases on Albany Molecular Research, Inc.:
One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials	8th May, 2009	Rensselaer Polytechnic Institute	TROY, N.Y., May 8 /PRNewswire-USNewswire/ -- For more than 10 years, Mark Wentland, professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, led a Rensselaer team in the

BioNews Results for Albany Molecular Research, Inc.:
AMRIEURs quarterly earnings, revenue down	San Francisco Business Times:  Nov 9 2009 3:06PM Matching: albany molecular research inc
Third Compound from AMRI Bristol-Myers Squibb Collaboration Chosen for Preclinical Development	TradingMarkets:  Nov 9 2009 6:06AM Matching: albany molecular research inc
AMRI receives $750K milestone payment	Charlotte Business Journal:  Nov 2 2009 9:27PM Matching: albany molecular research inc
AMRI receives $750K milestone payment	Business Review Albany:  Nov 2 2009 4:35PM Matching: albany molecular research inc
AMRI receives $750K milestone payment	Biz Journals:  Nov 2 2009 4:22PM Matching: albany molecular research inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Albany Molecular Research, Inc. news.

Albany Molecular Research, Inc. Clinical Trials:
A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors

Albany Molecular Research, Inc. Patents:
US Patent No.	Title
7560561	Process for production of piperidine derivatives
6406670	Multiple well microtiter plate loading assembly and method
6261813	Two step enzymatic acylation
6201124	Process for production of piperidine derivatives
6153754	Process for production of piperidine derivatives
→View more Albany Molecular Research, Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 223 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in Albany

Search for more companies in New York

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Albany Molecular Research, Inc.